Found: 12
Select item for more details and to access through your institution.
Pituitary Tumors: Genetic and Molecular Factors Underlying Pathogenesis and Clinical Behavior.
- Published in:
- Neuroendocrinology, 2022, v. 112, n. 1, p. 15, doi. 10.1159/000514862
- By:
- Publication type:
- Article
Beta-Arrestin 2 Is Required for Dopamine Receptor Type 2 Inhibitory Effects on AKT Phosphorylation and Cell Proliferation in Pituitary Tumors.
- Published in:
- Neuroendocrinology, 2021, v. 111, n. 6, p. 568, doi. 10.1159/000509219
- By:
- Publication type:
- Article
Cytoskeleton Protein Filamin A Is Required for Efficient Somatostatin Receptor Type 2 Internalization and Recycling through Rab5 and Rab4 Sorting Endosomes in Tumor Somatotroph Cells.
- Published in:
- Neuroendocrinology, 2020, v. 110, n. 7/8, p. 642, doi. 10.1159/000503791
- By:
- Publication type:
- Article
Stem Cells in Pituitary Tumors: Experimental Evidence Supporting Their Existence and Their Role in Tumor Clinical Behavior.
- Published in:
- Frontiers in Endocrinology, 2019, v. 10, p. 1, doi. 10.3389/fendo.2019.00745
- By:
- Publication type:
- Article
A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells.
- Published in:
- Cancers, 2023, v. 15, n. 12, p. 3218, doi. 10.3390/cancers15123218
- By:
- Publication type:
- Article
P720R USP8 Mutation Is Associated with a Better Responsiveness to Pasireotide in ACTH-Secreting PitNETs.
- Published in:
- Cancers, 2022, v. 14, n. 10, p. 2455, doi. 10.3390/cancers14102455
- By:
- Publication type:
- Article
Genetic Profiling of a Cohort of Italian Patients with ACTH-Secreting Pituitary Tumors and Characterization of a Novel USP8 Gene Variant.
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 4022, doi. 10.3390/cancers13164022
- By:
- Publication type:
- Article
A Novel Mechanism Regulating Dopamine Receptor Type 2 Signal Transduction in Pituitary Tumoral Cells: The Role of cAMP/PKA-Induced Filamin A Phosphorylation.
- Published in:
- Frontiers in Endocrinology, 2021, v. 11, p. N.PAG, doi. 10.3389/fendo.2020.611752
- By:
- Publication type:
- Article
DRD2 Agonist Cabergoline Abolished the Escape Mechanism Induced by mTOR Inhibitor Everolimus in Tumoral Pituitary Cells.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.867822
- By:
- Publication type:
- Article
TMPRSS2 Expression and Activity Modulation by Sex-Related Hormones in Lung Calu-3 Cells: Impact on Gender-Specific SARS-CoV-2 Infection.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.862789
- By:
- Publication type:
- Article
Dopamine and Somatostatin Analogues Resistance of Pituitary Tumors: Focus on Cytoskeleton involvement.
- Published in:
- Frontiers in Endocrinology, 2015, v. 6, p. 1, doi. 10.3389/fendo.2015.00187
- By:
- Publication type:
- Article
The Novel SSTR3 Agonist ITF2984 Exerts Antimitotic and Proapoptotic Effects in Human Non-Functioning Pituitary Neuroendocrine Tumor (NF-PitNET) Cells.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 7, p. 3606, doi. 10.3390/ijms25073606
- By:
- Publication type:
- Article